Clinical implications of midazolam in preoperative anxiety and sedation: a review
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20243011Keywords:
Preoperative anxiety, Midazolam, Sedation, Anxiolysis, BenzodiazepinesAbstract
Preoperative anxiety, a common reaction to the unfamiliar setting of medical procedures, affects 60-80% of patients and can lead to significant psychological and physiological stress. This stress can exacerbate hemodynamic instability during surgery, complicate anesthetic management, and contribute to adverse postoperative outcomes such as increased pain perception, longer recovery times, and extended hospital stays. Midazolam, a short-acting benzodiazepine, is frequently used to address these issues due to its rapid onset and effective anxiolytic and sedative properties. By acting on GABA-A receptors, midazolam provides relief from preoperative anxiety and facilitates smoother anesthesia induction. However, its use is not without risks, including potential respiratory depression, paradoxical reactions, and oversedation, which may be particularly concerning in vulnerable populations. These concerns have prompted exploration of non-pharmacological approaches, such as cognitive-behavioral therapy and mindfulness-based interventions, which can reduce anxiety without the side effects associated with pharmacological agents. This review aims to critically evaluate the clinical implications of midazolam use for preoperative anxiety and sedation, highlighting its efficacy, safety profile, and the growing interest in alternative non-pharmacological strategies.
Metrics
References
Corman HH, Hornick EJ, Kritchman M, Terestman N. Emotional reactions of surgical patients to hospitalization, anesthesia and surgery. Am J Surg. 1958;96(5):646-53.
Wallace LM. Psychological preparation as a method of reducing the stress of surgery. J Human Stress. 1984;10(2):62-77.
Caumo W, Ferreira MBC. Perioperative anxiety: psychobiology and effects in postoperative recovery. Pain Clinic. 2003;15(2):87-101.
Lang EV, Benotsch EG, Fick LJ, Lutgendorf S, Berbaum ML, Berbaum KS, et al. Adjunctive non-pharmacological analgesia for invasive medical procedures: a randomised trial. Lancet. 2000;355(9214):1486-90.
Hung C, Chow Y, Fung C, Koo C, Lui K, Lam A. Safety and comfort during sedation for diagnostic or therapeutic procedures. Hong Kong Med J. 2002;8(2):114.
Apfelbaum J, Gross J, Connis R. Practice guidelines for moderate procedural sedation and analgesia 2018: a report by the American Society of Anesthesiologists Task Force on moderate procedural sedation and analgesia, the American Association of Oral and Maxillofacial Surgeons, American College of Radiology, American dental association, American Society of Dentist Anesthesiologists, and Society of Interventional Radiology. Anesthesiology. 2018;128(3):437-79.
Kain ZN, Mayes LC, Bell C, Weisman S, Hofstadter MB, Rimar S. Premedication in the United States: a status report. Anesth Anal. 1997;84(2):427-32.
Bauer KP, Dom PM, Ramirez AM, O'Flaherty JE. Preoperative intravenous midazolam: benefits beyond anxiolysis. J Clin Anesth. 2004;16(3):177-83.
Meyer RE, Fish R. Pharmacology of injectable anesthetics, sedatives, and tranquilizers. In: Anesthesia and analgesia of laboratory animals. 2nd edition. San Diego: Academic. 2008.
Nguyen N, Pendyala G. Sedation with midazolam in the NICU: implications on neurodevelopment. Neuro Immune Pharmacol Ther. 2024;aop.
Naguib M, Samarkandi AH. The comparative dose-response effects of melatonin and midazolam for premedication of adult patients: a double-blinded, placebo-controlled study. Anesth Anal. 2000;91(2):473-9.
Bansal R, Joad ASK, Saxena M, Hemrajani M. Oral midazolam is a safe and effective premedication in adult outpatients undergoing brachytherapy for cancer cervix under general anaesthesia: a prospective randomised, double blind placebo-controlled study. Indian J Anaesth. 2015;59(7):437-9.
Bayrak A, Sagiroglu G, Copuroglu E. Effects of preoperative anxiety on intraoperative hemodynamics and postoperative pain. J Coll Physicians Surg Pak. 2019;29(9):868-73.
Conway A, Chang K, Mafeld S, Sutherland J. Midazolam for sedation before procedures in adults and children: a systematic review update. Syst Rev. 2021;10(1):69.
Wheeler DS, Jensen RA, Poss WB. A randomized, blinded comparison of chioral hydrate and midazolam sedation in children undergoing echocardiography. Clin Pediatr. 2001;40(7):381-7.
Akil I, Ozkol M, Ikizoglu OY, Polat M, Tuncyurek OY, Taskin O, et al. Premedication during micturating cystourethrogram to achieve sedation and anxiolysis. Pediatr Nephrol. 2005;20(8):1106-10.
D’Agostino J, Terndrup TE. Chloral hydrate versus midazolam for sedation of children for neuroimaging: a randomized clinical trial. Pediatr Emerg Care. 2000;16(1):1-4.
Salehi F, Riasi HR, Ebrahimzadeh A, Askari Janatabadi S. The effect of oral midazolam and chloral hydrate before echocardiography in pediatric patients: a randomized double-blind clinical trial. Global Pediatric Health. 2017;4:2333794X17735972.
Derakhshanfar H, Modanloo Kordi M, Amini A, Shojahee M. A comparative study on the sedative effect of oral midazolam and oral chloral hydrate medication in lumbar puncture. Acta Medica Croatica. 2013;67(5):405.
Neville DN, Hayes KR, Ivan Y, McDowell ER, Pitetti RD. Double‐blind randomized controlled trial of intranasal dexmedetomidine versus intranasal midazolam as anxiolysis prior to pediatric laceration repair in the emergency department. Acad Emerg Med. 2016;23(8):910-7.
Alp H, Elmacı AM, Alp EK, Say B. Comparison of intranasal midazolam, intranasal ketamine, and oral chloral hydrate for conscious sedation during paediatric echocardiography: results of a prospective randomised study. Cardiol Young. 2019;29(9):1189-95.
Cao J, Shi X, Miao X, Xu J. Effects of premedication of midazolam or clonidine on perioperative anxiety and pain in children. Biosci Trends. 2009;3(3):115-8.
Karunarathna I, Hapuarachchi T, Gunasena P, Rajapaksha S, Gunawardana K, Bandara S, et al. Midazolam: Pharmacology, Clinical Applications, and Safety Considerations. Uva Clinical Pharmacology; 2024.
Maxwell LG, Tobias JD, Cravero JP, Malviya S. Adverse effects of sedatives in children. Exp Opin Drug Safety. 2003;2(2):167-94.
Kuchta A, Golembiewski J. Medication use in the elderly patient: focus on the perioperative/ perianesthesia setting. J Peri Anesth Nurs. 2004;19(6):415-27.
Forster A, Gardaz J-P, Suter PM, Gemperle M. Respiratory depression by midazolam and diazepam. Anesthesiology. 1980;53(6):494-7.
Zhang Y, Zhang N, Hu J, Liu C, Li G. Safety and efficacy of a low-dose combination of midazolam, alfentanil, and propofol for deep sedation of elderly patients undergoing ERCP. BMC Gastroenterol. 2024;24(1):124.
Weinbroum A, Szold O, Ogorek D, Flaishon R. The midazolam-induced paradox phenomenon is reversible by flumazenil. Epidemiology, patient characteristics and review of the literature. Eur J Anaesthesiol. 2001;18(12):789-97.
McGloy R. Reversal of conscious sedation by flumazenil: current status and future prospects. Acta Anaesthesiol Scand. 1995;39:35-42.
Seger DL. Flumazenil—treatment or toxin. J Toxicol. 2004;42(2):209-16.
Wang R, Huang X, Wang Y, Akbari M. Non-pharmacologic approaches in preoperative anxiety, a comprehensive review. Front Public Health. 2022;10:854673.
Downloads
Published
How to Cite
Issue
Section
